(4R,4'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-(phenylmethyl)oxazole], 97%, 100mg

N-Isobutylpropionamide, 97.0%, 250mg

4-(4-Bromobenzoyl)morpholine, 95.0%, 1g

Lithium bromide, min. 99%, anhydrous, 100 g, plastic packaging.

4-BROMO-2-IODO-6-(TRIFLUOROMETHYL)ANILINE, 95%, 1g

1,8-Dibromoanthracene>98.0%(GC)5g

Hyflo supercel celite (c), 99%, 500g

2-Amino-5-bromo-3-fluorobenzaldehyde, 100mg

Eugenol>99.0%(GC)500mL

6-Methyl-3-thioxo-3,4-dihydro-2H-[1,2,4]triazin-5-one, 97%, 10g

(4aR,5R,6S)-4a-Hydroxy-6-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-5-vinyl-4,4a,5,6-tetrahydropyrano[3,4-c]pyran-1(3H)-one, 97%, 100mg

1-tert-butyl-4-phenyl-1H-pyrazol-5-amine, 95.0%, 1g

3-(2,2,2-Trifluoroethoxy)isonicotinic acid, 1g